<DOC>
	<DOC>NCT01733667</DOC>
	<brief_summary>The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack after FESS.</brief_summary>
	<brief_title>A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery</brief_title>
	<detailed_description>MediENT is designed to minimize lateralization of the middle turbinate, which can cause scarring and obstruction of key sinus openings after endoscopic sinus surgery.</detailed_description>
	<criteria>1. Subject is between the ages of 18 and 65 years 2. Subject scheduled to undergo bilateral endoscopic sinus surgery 3. Subject signs IRBapproved informed consent form 4. Subject agrees to comply with all studyrelated procedures 1. History of removal of one or both middle turbinates 2. Significant sinonasal polyps 3. Presence of marked septal asymmetry 4. Presence of significant concha bullosa, which requires surgical excision 5. Presence of nonviable tissue at the implantation site 6. Has an autoimmune disease, e.g., lupus, Graves' disease, myasthenia gravis, Wegener's granulomatosis 7. Known or suspected allergy to device components 8. Participating in another clinical trial which could affect the healing of the middle turbinate 9. Uncontrolled diabetes 10. Known or suspected use of illicit drugs 11. Known or suspected alcoholism 12. Other medical illness that could prevent followup or increase the risk of surgery 13. Pregnant or unwilling to take pregnancy prevention measures 14. Subject is currently using CPAP (Continuous Positive Airway Pressure) for sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>synechia</keyword>
	<keyword>Fess</keyword>
	<keyword>sinus surgery</keyword>
</DOC>